RHYTHM PHARMACEUTICALS, INC. (RYTM) is a publicly traded company in the Unknown sector. Across all available filings, 42 corporate insiders have executed 408 transactions totaling $235.4M, demonstrating a bearish sentiment with -$1.5M in net insider flow. The most recent transaction on Dec 11, 2025 involved a sale of 3,350 shares valued at $371.9K.
No significant insider buying has been recorded for RYTM in the recent period.
No significant insider selling has been recorded for RYTM in the recent period.
Based on recent SEC filings, insider sentiment for RYTM is bearish with an Insider Alignment Score of 50/100 and a net flow of -$1.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at RHYTHM PHARMACEUTICALS, INC. (RYTM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 42 insiders are actively trading RYTM stock, having executed 408 transactions in the past 90 days. The most active insider is Todd Foley (Executive), who has made 50 transactions totaling $62.3M.
Get notified when executives and directors at RYTM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | J. Cramer Pamela | Executive | Sale | 3,350 | $111.00 | $371.9K | |
| Dec 11, 2025 | J. Cramer Pamela | Executive | Option Exercise | 3,350 | $27.35 | $91.6K | |
| Nov 20, 2025 | J. Cramer Pamela | Executive | Option Exercise | 3,350 | $27.35 | $91.6K | |
| Nov 20, 2025 | J. Cramer Pamela | Executive | Sale | 3,350 | $105.00 | $351.8K | |
| Nov 10, 2025 | J. Cramer Pamela | Executive | Option Exercise | 3,515 | $6.80 | $23.9K | |
| Nov 10, 2025 | J. Cramer Pamela | Executive | Sale | 3,515 | $100.00 | $351.5K | |
| Nov 7, 2025 | J. Cramer Pamela | Executive | Option Exercise | 8,805 | $19.02 | $167.5K | |
| Nov 7, 2025 | J. Cramer Pamela | Executive | Sale | 19,351 | $98.82 | $1.9M | Large |
| Nov 7, 2025 | J. Cramer Pamela | Executive | Option Exercise | 10,546 | $6.80 | $71.7K | |
| Oct 30, 2025 | Shulman Joseph | Executive | Sale | 9,748 | $115.24 | $1.1M | Large |
| Oct 30, 2025 | Shulman Joseph | Executive | Option Exercise | 9,748 | $30.66 | $298.9K | |
| Oct 28, 2025 | Shulman Joseph | Executive | Sale | 2,815 | $115.01 | $323.8K | |
| Oct 28, 2025 | Shulman Joseph | Executive | Option Exercise | 721 | $30.66 | $22.1K | |
| Oct 28, 2025 | Shulman Joseph | Executive | Option Exercise | 2,094 | $27.35 | $57.3K | |
| Oct 16, 2025 | Shulman Joseph | Executive | Sale | 2,693 | $110.95 | $298.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 210 | $118.5M | 48.2% |
Purchase(P) | 20 | $117.0M | 47.6% |
Exercise(M) | 137 | $10.2M | 4.2% |
Award(A) | 5 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Gift(G) | 2 | $0 | 0.0% |
Conversion(C) | 32 | $0 | 0.0% |
Insider activity at RHYTHM PHARMACEUTICALS, INC. shows mixed signals across all time. While $117.0M in purchases indicates some executive confidence,$118.5M in sales balances the picture, resulting in a modest net flow of -$1.5M.42 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Todd Foley, has transacted $62.3M during this period.